NAPSRx

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, and QLT Inc., a Canadian-based biotechnology company made the official announcement of a definitive agreement to enter into a merger.

On Monday, June 23, 2014 Abbott made the official announcement of its plans to acquire the largest Russian pharmaceutical manufacturer, Veropharm.

Vertex, a global biotechnology pioneer aims to discover, develop and commercialize innovative and advanced new medicines to significantly improve the lives of patients who are inflicted with debilitating diseases.

Cubist Pharmaceuticals, Inc announced on Friday, June 20, 2014 that the U.S. Food and Drug Administration (FDA) approved Sivextro to treat bacterial skin infections.

The biotech/biopharma industry has been a core leader in the healthcare market for organic job creation thus fueling positive economic impact.

As one of the industry leaders in the healthcare sector - Novartis' new business structure and smaller portfolio may result in an increase in profits.

The new collaborative effort to develop a single tablet for HIV treatment by industry leaders J &J and Glaxo (Viiv Healthcare) could significantly improve the lives of HIV patients, if successful.

Avion Pharmaceuticals focuses on the development of marketing innovative products in the Women’s Heath and Dermatology therapeutic area.

A study by Belgian doctoral researcher Wouter De Haes (KU Leuven) and colleagues provides new evidence that metformin, the world's most widely used anti-diabetic drug, slows ageing and increases lifespan.

Eli Lilly and Co. said its Type II diabetes drug was more effective than Sanofi SA's approved drug Lantus in reducing patients' blood sugar levels in 3 late-stage trials.